Tag: Danbury

Posted on

Danbury Asthma Sufferers: Air Quality Alert Issued for Wednesday – Patch.com


Patch.com

Danbury Asthma Sufferers: Air Quality Alert Issued for Wednesday
Patch.com
In the cold season, particle pollution predominates," the U. S. Environmental Protection Agency (EPA) said, continuing, "Health effects such as: aggravated asthma, chronic bronchitis, nonfatal heart attacks, and even pre-mature death in people with …
First "Code Orange" ozone alert issued for Hamilton CountyWTVC
Air quality alert issued Tuesday for East TennesseeWBIR.com
Air quality health advisory issued for ozone pollution today: L.I., NYC metroSoutholdLOCAL

all 57 news articles »

View full post on asthma – Google News

Posted on

Boehringer Ingelheim’s asthma drug wins FDA approval – Danbury News Times


Danbury News Times

Boehringer Ingelheim's asthma drug wins FDA approval
Danbury News Times
DANBURY — Nearly one in 10 adults in Connecticut – 9.2 percent – has asthma. Boehringer Ingelheim, the Danbury-based pharmaceutical company cited the figure as it announced the federally approved availability of its new Spiriva Respimat product for …
Spiriva Respimat Now Available in Pharmacies for Asthma PatientsPharmacy Times

all 3 news articles »

View full post on asthma – Google News

Posted on

Travel Requires Special Planning for Those with Allergy-Induced Asthma – Danbury News Times

Travel Requires Special Planning for Those with Allergy-Induced Asthma
Danbury News Times
The board certified specialists at Hudson Valley Ear, Nose & Throat (ENT) have created a checklist for their patients with allergy-induced asthma to help them plan ahead, pack smart, and travel wisely for easy breathing while away from home. “Common …

and more »

View full post on asthma – Google News

Posted on

Medication Adherence Pilot For Asthma and COPD Reveals Nearly 76 Percent … – Danbury News Times

Medication Adherence Pilot For Asthma and COPD Reveals Nearly 76 Percent …
Danbury News Times
HealthPrize Technologies, LLC, a leading innovator in medication adherence solutions, announced today the results of a six-month asthma and chronic obstructive pulmonary disease (COPD) pilot that tested engagement with its online and mobile platform.

View full post on asthma – Google News